GT Biopharma (OXIA.F) Q3 2024 Earnings

14AugConfirmed
Q2 2024
Q3 2024
-2.48
-2.15
-1.83
-1.51

Details

Expected EPS
-2.4516000000000004
Actual EPS
-1.97036
Surprise EPS
0.48
Surprise Percent
+19.63%

Description

GT Biopharma (OXIA.F) has reported earnings of -1.97036 per share for Q3 2024.

0 Comments

Share your thoughts